Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. (Q53356778)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

Cytomegalovirus

0 references

1 reference

based on heuristic

inferred from title

author name string

E Gane

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

F Saliba

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

G J Valdecasas

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

J O'Grady

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

M D Pescovitz

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

S Lyman

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

C A Robinson

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

language of work or name

0 references

publication date

1 December 1997

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

350

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

9093

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

1729-1733

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

Cytomegalovirus prophylaxis in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical patterns of cytomegalovirus disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Donated organ as a source of cytomegalovirus in orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost impact of cytomegalovirus disease in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(97)05535-9

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53356778&oldid=2104965270"